Paclitaxel prodrug nanoparticles boost antitumor efficacy via hitchhiking of human serum albumin
Shaojin Lu,
No information about this author
Shiyu Zhou,
No information about this author
Xiujuan Xiang
No information about this author
et al.
Journal of Colloid and Interface Science,
Journal Year:
2024,
Volume and Issue:
679, P. 144 - 154
Published: Oct. 16, 2024
Language: Английский
Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
Abstract
Activating
specific
immunity
through
intelligent
delivery
of
chemotherapeutic
drugs
shows
great
potential
for
effective
tumor
therapy.
However,
conventional
microenvironment‐responsive
nanomedicines
are
often
difficult
to
achieve
both
specificity
and
sensitivity,
leading
severe
adverse
effects
or
limited
drug
release
efficiency.
Furthermore,
the
immunosuppressive
microenvironment
will
also
seriously
restrict
treatment
efficacy.
In
this
work,
a
cascade‐responsive
multi‐polyprodrug
nanoregulator
is
developed.
Under
with
high
hydrogen
peroxide
level,
nanoregulators
can
simultaneously
(doxorubicin),
indoleamine
2,3‐dioxygenase
1
inhibitor
(1‐methyl‐tryptophan)
cinnamaldehyde
in
self‐accelerating
manner.
The
combination
reactive
oxygen
species‐induced
ferroptosis
doxorubicin‐induced
apoptosis
synergistically
enhance
immunogenic
cell
death
activate
immune
response.
released1‐methyl‐tryptophan
promote
cytotoxic
T
lymphocyte
activation
reduce
escape
by
inhibiting
tryptophan
conversion.
Meanwhile,
it
enhances
species
scavenging
cystine/glutamate
antiporter
expression,
achieving
positive
feedback
ferroptosis‐immunotherapy.
This
work
provides
self‐accelerated
strategy
cooperation
mode
synergistic
immunotherapy
based
on
ferroptosis‐apoptosis.
Language: Английский
Histone deacetylase inhibiting nanoprodrugs for enhanced chemodynamic therapy through multistage downregulating glutathione
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
305, P. 141184 - 141184
Published: Feb. 17, 2025
Language: Английский
Nanotherapeutics induced redox resetting of oxidative and nitrosative stress: targeting glutathione-depletion in cancer
Kapil Dangi,
No information about this author
Vijay Kumar,
No information about this author
Disha Mittal
No information about this author
et al.
Nanomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 11
Published: April 7, 2025
Cancer
cells
display
a
distinctive
defense
mechanism
against
any
exogenous
moieties
that
renders
all
treatments
inefficient.
Glutathione,
thiol
tripeptide
plays
paradoxical
role
in
cancer
as
intracellular
glutathione
(GSH)
are
voracious
scavengers
of
free
radicals
produced
by
chemotherapy,
generation
reactive
oxygen
species
(ROS)
and
nitrogen
(RNS).
show
Warburg
effect,
wherein
the
GSH
levels
exceptionally
enhanced
to
overcome
oxidative
stress
created
ROS/RNS
production
or
other
generated
side
products
redox
reactions.
Therefore,
resetting
is
essential
maintain
homeostasis
for
cell
survival
their
proliferation
trigger
escalation
levels.
Nanotherapeutics
have
facilitated
targeted
delivery
GSH-depleting
agents
combination
with
radiotherapy,
novel
therapeutic
interventions
including
chemodynamic
therapy
(CDT),
photodynamic
(PDT),
ferroptosis
induction,
sonodynamic
(SDT),
immunotherapy
being
explored.
This
review
aims
compile
strategic
cells,
importance
nanotherapeutics
depletion
target
numerous
forms
programmed
death
(PCD),
apoptosis,
ferroptosis,
necroptosis,
autophagy.
Language: Английский